3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Classical hematology
1
Conditions
Neutropenia
1
Neoplasms
1
Hematologic Neoplasms
1
Fever
1
Febrile Neutropenia
1
Interventions
Meropenem
5
Ceftazidime
4
Levofloxacin
3
Filgrastim
3
Ciprofloxacin
3
Cefepime
3
Amikacin
3
pegfilgrastim
2
Vancomycin
2
Interleukin 1 Receptor Antagonist Protein
2
Anti-Bacterial Agents
2
Amoxicillin-Potassium Clavulanate Combination
2
pegylated granulocyte colony-stimulating factor
1
Therapeutics
1
Teicoplanin
1
Tazobactam
1
TKN732
1
Surveys and Questionnaires
1
Positron Emission Tomography Computed Tomography
1
Piperacillin
1
Ofloxacin
1
NF protocol
1
Micafungin
1
Metronidazole
1
Magnetic Resonance Myelography
1
Lead
1
Injections
1
Granulocyte Colony-Stimulating Factor
1
Cloxacillin
1
Cilastatin, Imipenem Drug Combination
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Febrile Neutropenia
×
Cilastatin, Imipenem Drug Combination
×
Clear all
NCT02149329
2019-09-25
SHORT
Amsterdam UMC, location VUmc
Phase 4
Completed
276 enrolled